Morgan Stanley Bluebird Bio, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Morgan Stanley holds 968,942 shares of BLUE stock, worth $290,682. This represents 0.0% of its overall portfolio holdings.

Number of Shares

968,942

Previous 516,034 87.77%

Holding current value

$290,682

Previous $505,000 0.4%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.47 - $1.35 $212,866 - $611,425	452,908 Added 87.77%	968,942 $503,000
Q2 2024 Oct 17, 2024	SELL	$0.85 - $1.26 $648,397 - $961,153	-762,820 Reduced 59.65%	516,034 $505,000
Q2 2024 Aug 14, 2024	SELL	$0.85 - $1.26 $648,397 - $961,153	-762,820 Reduced 59.65%	516,034 $505,000
Q1 2024 Oct 17, 2024	BUY	$0.91 - $1.75 $694,166 - $1.33 Million	762,820 Added 147.82%	1,278,854 $1.64 Million
Q1 2024 Aug 16, 2024	BUY	$0.91 - $1.75 $60,376 - $116,109	66,348 Added 5.47%	1,278,854 $1.64 Million
Q1 2024 May 15, 2024	BUY	$0.91 - $1.75 $60,376 - $116,109	66,348 Added 5.47%	1,278,854 $1.64 Million
Q4 2023 Aug 16, 2024	BUY	$1.32 - $4.83 $919,343 - $3.36 Million	696,472 Added 134.97%	1,212,506 $1.67 Million
Q4 2023 Feb 13, 2024	BUY	$1.32 - $4.83 $1.05 Million - $3.82 Million	791,728 Added 188.16%	1,212,506 $1.67 Million
Q3 2023 Nov 15, 2023	SELL	$3.02 - $4.05 $136,005 - $182,391	-45,035 Reduced 9.67%	420,778 $1.28 Million
Q2 2023 Aug 14, 2023	SELL	$2.79 - $5.03 $150,224 - $270,835	-53,844 Reduced 10.36%	465,813 $1.53 Million
Q1 2023 May 15, 2023	SELL	$3.14 - $8.22 $985,429 - $2.58 Million	-313,831 Reduced 37.65%	519,657 $1.65 Million
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $2.08 Million - $3.06 Million	360,612 Added 76.26%	833,488 $5.77 Million
Q3 2022 Nov 14, 2022	SELL	$3.75 - $7.39 $661,462 - $1.3 Million	-176,390 Reduced 27.17%	472,876 $2.99 Million
Q2 2022 Oct 27, 2022	SELL	$2.94 - $5.23 $2.72 Million - $4.83 Million	-923,539 Reduced 58.72%	649,266 $2.69 Million
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $2.72 Million - $4.83 Million	-923,539 Reduced 58.72%	649,266 $2.69 Million
Q1 2022 Oct 27, 2022	BUY	$4.07 - $10.6 $3.76 Million - $9.79 Million	923,539 Added 142.24%	1,572,805 $7.63 Million
Q1 2022 May 13, 2022	BUY	$4.07 - $10.6 $4.42 Million - $11.5 Million	1,085,725 Added 222.9%	1,572,805 $7.63 Million
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $1.72 Million - $3.14 Million	192,508 Added 65.35%	487,080 $4.87 Million
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $3.31 Million - $6.19 Million	294,572 New	294,572 $5.63 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $23.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account